Search Results for "Spirogen Seattle Genetics"
Matching Channels
In biology, and specifically genetics, epigenetics is the study of changes in gene expression caused by mechanisms other than changes in the underlying DNA sequence – hence the name epi- (Gree...
Personalized medicines are a new therapeutic option that takes into account the genetics and individuality of patients diseases, and then develops or prescribes drug that are likely to have the most...
A virus is a small infectious agent that can replicate only inside the living cells of organisms. Virus particles (known as virions) consist of two or three parts: the genetic material made from eit...
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common ca...
Crohns Disease is a chronic inflammatory disease, affecting the whole of the alimentary tract from mouth to anus, and all layers of the gut wall. The most commonly affected sites are the terminal il...
Matching News
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul
Just glance at the name, Seattle Genetics, and you get the drift this is a science-based company. But Seattle Genetics is morphing into something bigger and more valuable, which creates a whole new ch...
Seattle Genetics, Abbott expand antibody deal
Seattle Genetics Inc. (NASDAQ:SGEN) and Abbott Laboratories (NYSE:ABT) expanded a 2011 deal for Seattle Genetics' antibody-drug conjugate (ADC) technology. Abbott will pay Seattle Genetics' $25 millio...
Seattle Genetics bags new milestones under Genentech ADC collaboration
Seattle Genetics has earned undisclosed milestone payments under its antibody-drug conjugate (ADC) collaboration with Roche's Genentech unit after Genentech advanced two ADCs developed with Seattle G...
Seattle Genetics expands collaboration with Abbott
Seattle Genetics Inc. said Tuesday that pharmaceutical giant Abbott Laboratories has agreed to pay $25 million plus potential milestone payments for the biotech firm's experimental antibodies to figh...
Seattle Genetics 2Q revenue misses estimates
Seattle Genetics Inc. said Wednesday that sales of its lymphoma drug Adcetris totaled $34.7 million in the second quarter, up slightly from the first quarter. The results missed analysts' estimates.A...
Seattle Genetics Inc. Presents at UBS Global Healthcare Conference, May-21-2013 11:30 AM
Seattle Genetics, Inc. (SGEN) May 21, 2013 11:30 am ET Executives Clay B. Siegall - Co-Founder, Chairman, Chief Executive Officer and President Presentation Unknown Analyst Good morning, e...
Ablynx, Spirogen set to evaluate novel anti-cancer drug conjugates
Ablynx and Spirogen have entered into a research collaboration to study and analyse the potential of a novel anti-cancer drug conjugate that combines Spirogen's proprietary cytotoxic drugs, pyrroloben...
Ablynx and Spirogen enter in research collaboration for toxin-nanobody drug conjugates
Ablynx and Spirogen Ltd. announced a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PB...
Matching PubMed Articles
Hepatoprotective and antiviral functions of silymarin components in HCV infection.
Introduction to the festschrift.
To determine the feasibility of using direct observation of provider-parent immunization discussions and to characterize provider communication practices with vaccine-hesitant parents.
Estimating the mutation rate of Mycobacterium tuberculosis during infection.
Current models of Mycobacterium tuberculosis latency presume very low mycobacterial replication and mutation rates. In contrast to these models, a study reporting whole-genome sequencing of mycobacter...
